共 108 条
[1]
de Gramont A.(2000)Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938-2947
[2]
Figer A.(2000)Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 1041-1047
[3]
Seymour M.(2004)Phase I study of CPT-11 and bolus 5-FU/l-leucovorin in patients with metastatic colorectal cancer Int J Clin Oncol 9 92-97
[4]
Homerin M.(2004)Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer Int J Clin Oncol 9 364-368
[5]
Hmissi A.(1958)Nonparametric estimation from incomplete observation J Am Stat Assoc 53 457-481
[6]
Cassidy J.(2000)Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer: Irinotecan Study Group N Engl J Med 343 905-914
[7]
Douillard J.Y.(2003)Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: results of EORTC GI Group study 40986 Proc Am Soc Clin Oncol 22 254-308
[8]
Cunningham D.(1998)Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer J Clin Oncol 16 301-30
[9]
Roth A.D.(2004)A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 23-2342
[10]
Navarro M.(2004)Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335-3705